Author:
Gaurav Khichariya,Manjula K,Subhashish Das,Kalyani R
Publisher
Heighten Science Publications Corporation
Reference16 articles.
1. 1. Mirshahi S, Pritchard LL, Pocard M, Mirshahi M, Soria J. Pathogenesis and Diagnosis of Venous Hypercoagulable States in Cancer. J Hematol Thrombo Dis. 2015; 3: 3.
2. 2. Chavez-MacGregor M, Zhao H, Kroll M, Fang S, Zhang N et al. Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. Ann Oncol. 2011; 22: 2394-2402. PubMed: https://pubmed.ncbi.nlm.nih.gov/21393379/
3. 3. Kirwan CC, McDowell G, McCollum CN, Byrne GJ. Incidence of Venous Thromboembolism during Chemotherapy for Breast Cancer: Impact on Cancer Outcome. Anticnacer Res. 2011; 31: 2383-2388. PubMed: https://pubmed.ncbi.nlm.nih.gov/21737669/
4. 4. Bremnes RM, Donnem T, Al-Saad S, Camps C, Marinez I, et al. The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer. J Thorac Oncol. 2011; 6: 209-217. PubMed: https://pubmed.ncbi.nlm.nih.gov/21107292/
5. Thrombosis and cancer;Dvorak;Hum Pathol,1987